Targeting metabolic vulnerabilities: REV-ERB agonist SR9009 potentiates sorafenib efficacy in liver cancer.
Saved in:
| Title: | Targeting metabolic vulnerabilities: REV-ERB agonist SR9009 potentiates sorafenib efficacy in liver cancer. |
|---|---|
| Authors: | Sabbioni S; Department of Life Sciences and Biotechnology, University of Ferrara, 44121, Ferrara, Italy. silvia.sabbioni@unife.it.; Laboratorio Per Le Tecnologie Delle Terapie Avanzate (LTTA), University of Ferrara, 44121, Ferrara, Italy. silvia.sabbioni@unife.it., Guerriero P; Department of Translational Medicine, University of Ferrara, 44121, Ferrara, Italy., Shankaraiah RC; Department of Translational Medicine, University of Ferrara, 44121, Ferrara, Italy.; Glaxo Smith Kline - Wavre Belgium Av. Fleming 20, 1300, Wavre, Belgium., Masatti L; Department of Translational Medicine, University of Ferrara, 44121, Ferrara, Italy.; Department of Biology, University of Padova, 35100, Padova, Italy., Michilli A; Department of Translational Medicine, University of Ferrara, 44121, Ferrara, Italy., Bassi C; Laboratorio Per Le Tecnologie Delle Terapie Avanzate (LTTA), University of Ferrara, 44121, Ferrara, Italy.; Department of Translational Medicine, University of Ferrara, 44121, Ferrara, Italy., D'Abundo L; Department of Translational Medicine, University of Ferrara, 44121, Ferrara, Italy., Moshiri F; Department of Translational Medicine, University of Ferrara, 44121, Ferrara, Italy., De Siena B; Department of Life Sciences and Biotechnology, University of Ferrara, 44121, Ferrara, Italy., Simoni E; Department of Translational Medicine, University of Ferrara, 44121, Ferrara, Italy.; Bioacoustics Research Laboratory, Department of Neurosciences, University of Padova, 35129, Padova, Italy., Astolfi L; Bioacoustics Research Laboratory, Department of Neurosciences, University of Padova, 35129, Padova, Italy., Gramantieri L; Division of Internal Medicine, Hepatobiliary and Immunoallergic Diseases, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138, Bologna, Italy., Roncarati R; Department of Translational Medicine, University of Ferrara, 44121, Ferrara, Italy.; CNR Institute of Molecular Genetics 'Luigi Luca Cavalli-Sforza', Unit of Bologna, Bologna, Italy., Elamin BK; Department of Microbiology and Clinical Parasitology, College of Medicine, University of Bisha, Bisha, 61922, Saudi Arabia.; Department of Medical Microbiology, Faculty of Medical Laboratory Sciences, University of Khartoum, Khartoum, Sudan., Bonora M; Department of Medical Sciences, Section of Experimental Medicine, University of Ferrara, 44121, Ferrara, Italy., Pinton P; Department of Medical Sciences, Section of Experimental Medicine, University of Ferrara, 44121, Ferrara, Italy., Croce CM; Department of Cancer Biology and Genetics, The Ohio State University, Columbus, OH, USA., Negrini M; Laboratorio Per Le Tecnologie Delle Terapie Avanzate (LTTA), University of Ferrara, 44121, Ferrara, Italy. massimo.negrini@unife.it.; Department of Translational Medicine, University of Ferrara, 44121, Ferrara, Italy. massimo.negrini@unife.it., Callegari E; Department of Translational Medicine, University of Ferrara, 44121, Ferrara, Italy. elisa.callegari@unife.it. |
| Source: | Cell death discovery [Cell Death Discov] 2026 Jan 19; Vol. 12 (1), pp. 86. Date of Electronic Publication: 2026 Jan 19. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: United States NLM ID: 101665035 Publication Model: Electronic Cited Medium: Print ISSN: 2058-7716 (Print) Linking ISSN: 20587716 NLM ISO Abbreviation: Cell Death Discov Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
